zolpidem
DrugOral
Other names: Myslee
NCT Number: NCT00653562
To evaluate the efficacy of zolpidem for adolescent insomniacs with polysomnography
Looking for future studies?
Notify Me12 year–18 year
All sexes
Interventional
Phase 4
Kansai, Japan
The study consists of two parts. All patients will receive placebo in one part and Zolpidem in the other part in a single blind manner. Efficacy will be measured with polysomnography .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral
Other names: Myslee
Time frame: 2 days
Time frame: 2 days
Time frame: 2 days
Time frame: 2 days
Time frame: 2 days
Astellas Pharma Inc
Industry
Single Blind, Multi-center, Post Marketing Clinical Study of Zolpidem (Myslee) in Adolescent Patients With Insomnia - Evaluation With Polysomnography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04598672
Chronic Disease, Disease Attributes
Oslo, Norway
View Trial DetailsNCT04560595
Anxiety, Anxiety Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT03636880
Anxiety, Anxiety Disorders
Columbus, Ohio, United States
View Trial DetailsNCT04598425
Anxiety Disorders, Behavior
Oslo, Norway
View Trial Details